[37] |
Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis[J]. N Engl J Med, 2018, 378(2): 169-180.
|
[38] |
Erturk A, Mauch CP, Hellal F, et al. Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury[J]. Nat Med, 2011, 18(1): 166-171.
|
[39] |
Spence RD, Kurth F, Itoh N, et al. Bringing CLARITY to gray matter atrophy[J]. Neuroimage, 2014, 101: 625-632.
|
[40] |
’t Hart BA, Laman JD, Kap YS. Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discovery[J]. Expert Opin Drug Discov, 2018, 13(5): 387-397.
|
[41] |
Carvalho RHF, Real CC, Cinini S, et al. [11C]PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis[J]. Mult Scler Relat Disord, 2019, 35: 108-115.
|
[42] |
Kalia LV, Lang AE. Parkinson’s disease[J]. Lancet, 2015, 386(9996): 896-912.
|
[43] |
Grayson M. Parkinson’s disease[J]. Nature, 2016, 538(7626): S1.
|
[44] |
Deniston CK, Salogiannis J, Mathea S, et al. Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction[J]. Nature, 2020, 588(7837): 344-349.
|
[45] |
Liu AK, Hurry ME, Ng OT, et al. Bringing CLARITY to the human brain: visualization of Lewy pathology in three dimensions[J]. Neuropathol Appl Neurobiol, 2016, 42(6): 573-587.
|
[46] |
Menegas W, Bergan JF, Ogawa SK, et al. Dopamine neurons projecting to the posterior striatum form an anatomically distinct subclass[J]. Elife, 2015, 4: e10032.
|
[47] |
Morissette M, Di Paolo T. Non-human primate models of PD to test novel therapies[J]. J Neural Transm (Vienna), 2018, 125(3): 291-324.
|
[48] |
Seo J, Lee Y, Kim BS, et al. A non-human primate model for stable chronic Parkinson’s disease induced by MPTP administration based on individual behavioral quantification[J]. J Neurosci Methods, 2019, 311: 277-287.
|
[1] |
Dugger BN, Dickson DW. Pathology of neurodegenerative diseases[J]. Cold Spring Harb Perspect Biol, 2017, 9(7): a028035.
|
[2] |
Kovacs GG. Molecular pathology of neurodegenerative diseases: principles and practice[J]. J Clin Pathol, 2019, 72(11): 725-735.
|
[3] |
Fisher EMC, Bannerman DM. Mouse models of neurodegeneration: Know your question, know your mouse[J]. Sci Transl Med, 2019, 11(493): eaaq1818.
|
[4] |
Bauman MD, Schumann CM. Advances in nonhuman primate models of autism: integrating neuroscience and behavior[J]. Exp Neurol, 2018, 299(Pt A): 252-265.
|
[5] |
Barbosa-Morais NL, Irimia M, Pan Q, et al. The evolutionary landscape of alternative splicing in vertebrate species[J]. Science, 2012, 338(6114): 1587-1593.
|
[6] |
Phillips KA, Bales KL, Capitanio JP, et al. Why primate models matter[J]. Am J Primatol, 2014, 76(9): 801-827.
|
[7] |
Chen XK, Kwan JS, Chang RC, et al. 1-phenyl 2-thiourea (PTU) activates autophagy in zebrafish embryos[J]. Autophagy, 2020: Online ahead of print.
|
[8] |
Marques JC, Li M, Schaak D, et al. Internal state dynamics shape brainwide activity and foraging behaviour[J]. Nature, 2020, 577(7789): 239-243.
|
[9] |
Susaki EA, Shimizu C, Kuno A, et al. Versatile whole-organ/body staining and imaging based on electrolyte-gel properties of biological tissues[J]. Nat Commun, 2020, 11(1): 1982.
|
[10] |
Susaki EA, Tainaka K, Perrin D, et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis[J]. Cell, 2014, 157(3): 726-739.
|
[11] |
蒲慕明.脑科学研究的三大发展方向[J].中国科学院院刊, 2019, 34(7): 807-813.
|
[12] |
Tainaka K, Kubota SI, Suyama TQ, et al. Whole-body imaging with single-cell resolution by tissue decolorization[J]. Cell, 2014, 159(4): 911-924.
|
[13] |
Richardson DS, Lichtman JW. Clarifying tissue clearing[J]. Cell, 2015, 162(2): 246-257.
|
[14] |
Jing D, Yi Y, Luo W, Zhang S, et al. Tissue clearing and its application to bone and dental tissues[J]. J Dent Res, 2019, 98(6): 621-631.
|
[15] |
Ueda HR, Erturk A, Chung K, et al. Tissue clearing and its applications in neuroscience[J]. Nat Rev Neurosci, 2020, 21(2): 61-79.
|
[16] |
王培新,张丹,尚爱加,等.组织透明技术[J].神经解剖学杂志, 2016, 32(1): 124-128.
|
[17] |
Høgh P. Alzheimer’s disease[J]. Ugeskr Laeger, 2017, 179(12): V09160686.
|
[18] |
Hodson R. Alzheimer’s disease[J]. Nature, 2018, 559(7715): S1.
|
[19] |
Briggs R, Kennelly SP, O’Neill D. Drug treatments in Alzheimer’s disease[J]. Clin Med (Lond), 2016, 16(3): 247-253.
|
[20] |
Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment[J]. F1000Res, 2018, 7: F1000
|
[21] |
Ando K, Laborde Q, Lazar A, et al. Inside Alzheimer brain with clarity: senile plaques, neurofibrillary tangles and axons in 3-D[J]. Acta Neuropathol, 2014, 128(3): 457-459.
|
[22] |
Liebmann T, Renier N, Bettayeb K, et al. Three-dimensional study of Alzheimer’s disease hallmarks using the iDISCO clearing method[J]. Cell Rep, 2016, 16(4): 1138-1152.
|
[23] |
Vints K, Vandael D, Baatsen P, et al. Modernization of Golgi staining techniques for high-resolution, 3-dimensional imaging of individual neurons[J]. Sci Rep, 2019, 9(1): 130.
|
[24] |
Li HW, Zhang L, Qin C. Current state of research on non-human primate models of Alzheimer’s disease[J]. Animal Model Exp Med, 2019, 2(4): 227-238.
|
[25] |
Gary C, Lam S, Herard AS, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate[J]. Acta Neuropathol Commun, 2019, 7(1): 126.
|
[26] |
Van Dam D, De Deyn PP. Non human primate models for Alzheimer’s disease-related research and drug discovery[J]. Expert Opin Drug Discov, 2017, 12(2): 187-200.
|
[27] |
Owens B. Amyotrophic lateral sclerosis[J]. Nature, 2017, 550(7676): S105.
|
[28] |
Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis[J]. N Engl J Med, 2017, 377(2): 162-172.
|
[29] |
Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis[J]. Nat Rev Dis Primers, 2017, 3: 17071.
|
[30] |
Hruska M, Henderson N, Marchand S, et al. Synaptic nanomodules underlie the organization and plasticity of spine synapses[J]. Nat Neurosci, 2018, 21(5): 671-682.
|
[31] |
Morawski M, Kirilina E, Scherf N, et al. Developing 3D microscopy with clarity on human brain tissue: towards a tool for informing and validating MRI-based histology[J]. Neuroimage, 2018, 182: 417-428.
|
[32] |
Lee E, Choi J, Jo Y, et al. ACT-PRESTO: rapid and consistent tissue clearing and labeling method for 3-dimensional (3D) imaging[J]. Sci Rep, 2016, 6: 18631.
|
[33] |
Uchida A, Sasaguri H, Kimura N, et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43[J]. Brain, 2012, 135(Pt 3): 833-846.
|
[34] |
Yin P, Guo X, Yang W, et al. Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains[J]. Acta Neuropathol, 2019, 137(6): 919-937.
|
[35] |
Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis[J]. Lancet, 2018, 391(10130): 1622-1636.
|
[36] |
Correale J, GaitanMI, Ysrraelit MC, et al. Progressive multiple sclerosis: from pathogenic mechanisms to treatment[J]. Brain, 2016, 140(3): 527-546.
|